PI Industries Limited (PIIND.NS) fair value

ACCE thesis

PI Industries makes agrochemicals for Indian and export markets, including crop protection chemicals and custom synthesis work for global agrochemical majors, with a contract manufacturing arm that supplies molecules to multinational customers. The moat rests on process chemistry know-how and long-running custom synthesis relationships, which tend to be sticky once a molecule is qualified, and the 57.6% gross margin reflects that specialisation. Revenue fell 10.4% in the latest reported year, so the near-term story depends on volume recovery in export agrochemicals and on the custom synthesis pipeline re-accelerating. The stock trades on 27.0 times trailing earnings but 19.5 times forward, which implies the market expects earnings to rebound sharply, so the case for a deeper look is whether management's order book and new molecule launches support that rebound. Operating margin of 15.5% against a 57.6% gross margin shows a heavy cost base between the two, which is the first thing to test.